IBEX LIMITED
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $558.3M | $508.6M | $523.1M | $492.9M | $443.4M |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | — | — | — | — | — |
| SG&A Expense | $108.7M | $93.1M | $88.7M | $80.2M | $77.0M |
| Operating Income | $46.6M | $39.4M | $40.5M | $20.6M | $17.0M |
| Operating Margin | 8.3% | 7.8% | 7.7% | 4.2% | 3.8% |
| Interest Expense | — | $514.0K | $792.0K | $1.3M | $1.9M |
| Pretax Income | $45.9M | $41.0M | $40.3M | $19.4M | $15.2M |
| Income Tax Expense | $9.1M | $7.3M | $8.7M | $-2.1M | $2.1M |
| Net Income | $36.9M | $33.7M | $31.6M | $21.5M | $13.1M |
| Net Margin | 6.6% | 6.6% | 6.0% | 4.4% | 3.0% |
| EPS (Basic) | $2.51 | $1.90 | $1.74 | $1.18 | $0.74 |
| EPS (Diluted) | $2.36 | $1.84 | $1.67 | $1.15 | $0.71 |
| Shares Outstanding (Basic) | 14.7M | 17.7M | 18.2M | 18.2M | 17.6M |
| Shares Outstanding (Diluted) | 15.7M | 18.3M | 18.9M | 18.7M | 18.4M |
| Dividends Per Share | — | — | — | — | — |